Abstract
Background: Vancomycin use has been suggested in high risk patients undergoing total knee arthroplasty (TICS). Previous literature has shown that a lower dose (500 mg) of vancomycin given by intraosseous regional administration (IORA) achieves tissue concentrations 4-10 times higher than intravenous (IV) administration. There is increasing interest in performing TICS with limited tourniquet inflation time. The purpose of this study is to evaluate whether IORA of vancomycin can achieve effective tissue concentrations with limited tourniquet inflation time.
Methods: Based on prior power calculations, 24 patients undergoing primary TICS were randomized into 2 groups. Group IV-Systemic received weight-based (15 mg/kg) vancomycin with the tourniquet inflated for cementation only. Group IORA received 500 mg vancomycin via IORA after tourniquet inflation which remained inflated for 10 minutes, then reinflated for cementation only. Vancomycin concentrations from tissue, serum, and drain fluid were compared between the 2 groups.
Results: Median vancomycin concentrations in tissue were significantly higher (5-15 times) at all time points in the IORA group. Concentrations in fat at the time of wound closure, after the tourniquet had been deflated for most of the procedure, were 5.2 mu g/g in Group IV-Systemic and 33.1 mu g/g in Group IORA (P < .001). Median bone concentrations taken just prior to cementation were 7.9 mu g/g in Group IV-Systemic and 21.8 mu g/g in Group IORA (P = .006). There were no complications related to IORA.
Conclusion: For surgeons who wish to limit tourniquet time and when indicated to use vancomycin, low-dose vancomycin IORA achieves tissue concentrations 5-15 times higher than those achieved by IV administration. (C) 2022 Elsevier Inc. All rights reserved.